| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b07bcd0e1cc7a836cec64d83bae2e4ad |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e3a6ec7303b7378aae8d01c5ccbe9d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_296e2e57410bb7ca10197c362ed8087e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_158d74feb588890ff90403cc18ea9349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83c8cfcc66f6c2d2a8ca5c6387a7e88a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_729a1f9113655d72401cdb16000007ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_396046c5f431809e29d8d897e05be312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b4c0c0c4d451dff06f5f2244432df0b |
| publicationDate |
2013-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130141271-A |
| titleOfInvention |
Antibiotic composition comprising ceftriaxone or a pharmaceutically acceptable salt thereof, sulbactam or a pharmaceutically acceptable salt thereof and 2-hydroxyethyl 12-hydroxyoctadecanoate |
| abstract |
The present invention relates to an antibiotic composition comprising ceftriaxone or a pharmaceutically acceptable salt thereof, sulbactam or a pharmaceutically acceptable salt thereof and 2-hydroxyethyl 12-hydroxyoctadecanoate. The composition is excellent in antimicrobial activity and can overcome in particular resistance to vector-lactamase-mediated antibiotic resistant strains and multidrug resistant strains. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102014116942-A1 |
| priorityDate |
2012-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |